Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.39 |
| ▸ | PREP | P48147 | 2/20 | 0.36 |
| ▸ | FAP | Q12884 | 1/20 | 0.36 |
| ▸ | P2RX3 | P56373 | 5/20 | 0.35 |
| ▸ | P2RX2 | Q9UBL9 | 5/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | IDH1 | O75874 | 1/20 | 0.31 |
| ▸ | NAMPT | P43490 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2508202 | 0.89 | HRH3 (0.40) | HRH3PREPFAPP2RX3P2RX2 | |
| SCHEMBL12196635 | 0.86 | CYP3A4 (0.42) | HRH3PREPFAP | |
| SCHEMBL18059599 | 0.86 | CYP3A4 (0.42) | HRH3PREPFAP | |
| SCHEMBL2504992 | 0.83 | HRH3 (0.42) | HRH3PREPFAPP2RX3P2RX2 | |
| SCHEMBL12196758 | 0.82 | MAOA (0.44) | HRH3PREPFAP | |
| SCHEMBL2478686 | 0.80 | MAOA (0.33) | — | |
| SCHEMBL12196690 | 0.79 | MAOA (0.46) | HRH3PREPFAP | |
| SCHEMBL2501176 | 0.77 | KDM1A (0.40) | — | |
| SCHEMBL12196674 | 0.77 | MAOA (0.40) | HRH3PREPFAP | |
| SCHEMBL12197576 | 0.76 | MAOA (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841306-B2 | Antimicrobials | PANACEA BIOTEC LTD. (IN) | 2014-09-23 | — | — | US | disclosed |
| US-20110245258-A1 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LTD. (IN) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245258-A1 | NOVEL ANTIMICROBIALS | ECI1, XDH, CYP3A4 | HRH3 3730/4885PREP 982/4885FAP 2179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.